메뉴 건너뛰기




Volumn 58, Issue 6, 2013, Pages 1258-1259

Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON ALPHA2A; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; RECOMBINANT PROTEIN; VIRUS RNA;

EID: 84877923967     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.12.019     Document Type: Letter
Times cited : (23)

References (9)
  • 1
    • 33748943782 scopus 로고    scopus 로고
    • Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
    • C. Castelnau, F. Le Gal, M.P. Ripault, E. Gordien, M. Martinot-Peignoux, and N. Boyer Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up Hepatology 44 2006 728 735
    • (2006) Hepatology , vol.44 , pp. 728-735
    • Castelnau, C.1    Le Gal, F.2    Ripault, M.P.3    Gordien, E.4    Martinot-Peignoux, M.5    Boyer, N.6
  • 2
    • 33748925036 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis D: New advances, old challenges
    • P. Farci Treatment of chronic hepatitis D: new advances, old challenges Hepatology 44 2006 536 539
    • (2006) Hepatology , vol.44 , pp. 536-539
    • Farci, P.1
  • 5
    • 33748947285 scopus 로고    scopus 로고
    • Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
    • G.A. Niro, A. Ciancio, G.B. Gaeta, A. Smedile, A. Marrone, and A. Olivero Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta Hepatology 44 2006 713 720
    • (2006) Hepatology , vol.44 , pp. 713-720
    • Niro, G.A.1    Ciancio, A.2    Gaeta, G.B.3    Smedile, A.4    Marrone, A.5    Olivero, A.6
  • 6
  • 8
    • 34548759780 scopus 로고    scopus 로고
    • 72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs peginterferon alpha-2a plus placebo vs adefovir in chronic delta hepatitis
    • H. Wedemeyer, C. Yurdaydin, G. Dalekos, A. Erhardt, Y. Cakaloglu, and H. Degertekin 72 week data of the HIDIT-1 trial: a multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs peginterferon alpha-2a plus placebo vs adefovir in chronic delta hepatitis J Hepatol 46 2007 S4
    • (2007) J Hepatol , vol.46 , pp. 4
    • Wedemeyer, H.1    Yurdaydin, C.2    Dalekos, G.3    Erhardt, A.4    Cakaloglu, Y.5    Degertekin, H.6
  • 9
    • 35248877520 scopus 로고    scopus 로고
    • A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis
    • C. Yurdaydin, H. Bozkaya, H. Karaaslan, F.O. Onder, O.E. Erkan, and K. Yalcin A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis J Viral Hepat 14 2007 812 816
    • (2007) J Viral Hepat , vol.14 , pp. 812-816
    • Yurdaydin, C.1    Bozkaya, H.2    Karaaslan, H.3    Onder, F.O.4    Erkan, O.E.5    Yalcin, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.